Observational findings from the Women’s Health Initiative study found that an intentional weight loss regimen by postmenopausal obese women can slash their risk of endometrial cancer by 29% to 56%.
An intentional weight loss regimen by postmenopausal obese women can slash their risk of endometrial cancer by 29% to 56%. These observational findings from the Women’s Health Initiative study were published in the Journal of Clinical Oncology.
Endometrial cancer is the fourth most common cancer among women in the United States, and the association between it and obesity has been studied by scientists for a while. However, the effect of weight loss in postmenopausal women and their risk of developing this cancer remains unknown. The choice of the study population is important because more than 75% of endometrial cancers are diagnosed in women 55 and older.
This observational study initially included 93,676 postmenopausal women, between 50 and 79 years old, who were a part of the Women’s Health Initiative. The women, were recruited at 40 clinical centers across the country between September 1, 1993, and December 31, 1998. Information on menopausal hormonal therapy and other covariates of interest was gathered using a combination of questionnaires and personal interviews. Exclusion criteria included:
Authors gathered data on 36,793 women to analyze further. Participants’ weight was measured at both the beginning of the study and 3 years later to calculate change in body weight. Women who lost weight were also asked at this time whether their weight loss was voluntary or involuntary.
During a median 11.4-year follow-up, 566 women developed endometrial cancer. The researchers found that women who were successful with their weight loss regimen saw a significant reduction in their risk of endometrial cancer compared with women whose weight remained stable during this period. Furthermore:
“Many older adults think it’s too late to benefit from weight loss, or think that because they are overweight or obese, the damage has already been done. But our findings show that’s not true,” study author Juhua Luo, PhD, an associate professor of epidemiology and biostatistics at the Indiana University School of Public Health in Bloomington, Indiana, said in a statement.
The authors hope that their findings will motivate weight loss programs in obese postmenopausal women.
Reference
Luo J, Chlebowski RT, Hendryx M, et al. Intentional weight loss and endometrial cancer risk [published online February 6, 2017]. J Clin Oncol. doi: 10.1200/JCO.2016.70.5822.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Many Patients With Psoriasis in Clinical Trials Experience Nocebo Effects, Study Finds
April 18th 2024Half of patients exposed to placebo in clinical trials experienced adverse events (AEs), which may be partially explainable by nocebo effects, according to a recent review and meta-analysis.
Read More
Low-Volume Hospitals Had Higher Reoperation Rate, Postoperative Complications in CRC
April 18th 2024Patients opting for elective colorectal surgery to address colorectal cancer (CRC) could have different rates of reoperation and postoperative complications based on the size of the hospital.
Read More